Literature DB >> 17300176

Crystal structure of Homo sapiens kynureninase.

Santiago Lima1, Roman Khristoforov, Cory Momany, Robert S Phillips.   

Abstract

Kynureninase is a member of a large family of catalytically diverse but structurally homologous pyridoxal 5'-phosphate (PLP) dependent enzymes known as the aspartate aminotransferase superfamily or alpha-family. The Homo sapiens and other eukaryotic constitutive kynureninases preferentially catalyze the hydrolytic cleavage of 3-hydroxy-l-kynurenine to produce 3-hydroxyanthranilate and l-alanine, while l-kynurenine is the substrate of many prokaryotic inducible kynureninases. The human enzyme was cloned with an N-terminal hexahistidine tag, expressed, and purified from a bacterial expression system using Ni metal ion affinity chromatography. Kinetic characterization of the recombinant enzyme reveals classic Michaelis-Menten behavior, with a Km of 28.3 +/- 1.9 microM and a specific activity of 1.75 micromol min-1 mg-1 for 3-hydroxy-dl-kynurenine. Crystals of recombinant kynureninase that diffracted to 2.0 A were obtained, and the atomic structure of the PLP-bound holoenzyme was determined by molecular replacement using the Pseudomonas fluorescens kynureninase structure (PDB entry 1qz9) as the phasing model. A structural superposition with the P. fluorescens kynureninase revealed that these two structures resemble the "open" and "closed" conformations of aspartate aminotransferase. The comparison illustrates the dynamic nature of these proteins' small domains and reveals a role for Arg-434 similar to its role in other AAT alpha-family members. Docking of 3-hydroxy-l-kynurenine into the human kynureninase active site suggests that Asn-333 and His-102 are involved in substrate binding and molecular discrimination between inducible and constitutive kynureninase substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300176      PMCID: PMC2531291          DOI: 10.1021/bi0616697

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  58 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  X-ray structure of MalY from Escherichia coli: a pyridoxal 5'-phosphate-dependent enzyme acting as a modulator in mal gene expression.

Authors:  T Clausen; A Schlegel; R Peist; E Schneider; C Steegborn; Y S Chang; A Haase; G P Bourenkov; H D Bartunik; W Boos
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

3.  Purification and biochemical characterization of some of the properties of recombinant human kynureninase.

Authors:  Harold A Walsh; Nigel P Botting
Journal:  Eur J Biochem       Date:  2002-04

4.  Degradation pathway of the phosphonate ciliatine: crystal structure of 2-aminoethylphosphonate transaminase.

Authors:  Celia C H Chen; H Zhang; A D Kim; A Howard; G M Sheldrick; D Mariano-Dunaway; O Herzberg
Journal:  Biochemistry       Date:  2002-11-05       Impact factor: 3.162

5.  Cloning and recombinant expression of rat and human kynureninase.

Authors:  S Toma; M Nakamura; S Toné; E Okuno; R Kido; J Breton; N Avanzi; L Cozzi; C Speciale; M Mostardini; S Gatti; L Benatti
Journal:  FEBS Lett       Date:  1997-05-12       Impact factor: 4.124

6.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

7.  Activated human microglia produce the excitotoxin quinolinic acid.

Authors:  M G Espey; O N Chernyshev; J F Reinhard; M A Namboodiri; C A Colton
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

8.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

Authors:  D Giulian; K Vaca; C A Noonan
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

9.  Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

Authors:  C L Achim; M P Heyes; C A Wiley
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  The structural basis for the altered substrate specificity of the R292D active site mutant of aspartate aminotransferase from E. coli.

Authors:  S C Almo; D L Smith; A T Danishefsky; D Ringe
Journal:  Protein Eng       Date:  1994-03
View more
  13 in total

1.  Lessons from high-throughput protein crystallization screening: 10 years of practical experience.

Authors:  Joseph R Luft; Edward H Snell; George T Detitta
Journal:  Expert Opin Drug Discov       Date:  2011-03-22       Impact factor: 6.098

2.  HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

Authors:  Todd Bradley; Guang Yang; Olga Ilkayeva; T Matt Holl; Ruijun Zhang; Jinsong Zhang; Sampa Santra; Christopher B Fox; Steve G Reed; Robert Parks; Cindy M Bowman; Hilary Bouton-Verville; Laura L Sutherland; Richard M Scearce; Nathan Vandergrift; Thomas B Kepler; M Anthony Moody; Hua-Xin Liao; S Munir Alam; Roger McLendon; Jeffrey I Everitt; Christopher B Newgard; Laurent Verkoczy; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

Review 3.  Structure, mechanism, and substrate specificity of kynureninase.

Authors:  Robert S Phillips
Journal:  Biochim Biophys Acta       Date:  2010-12-15

Review 4.  General base-general acid catalysis by terpenoid cyclases.

Authors:  Travis A Pemberton; David W Christianson
Journal:  J Antibiot (Tokyo)       Date:  2016-04-13       Impact factor: 2.649

5.  New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder.

Authors:  Justin O Szot; Anne Slavotinek; Karen Chong; Oliver Brandau; Marjan Nezarati; Anna M Cueto-González; Millan S Patel; Walter P Devine; Shannon Rego; Alicia P Acyinena; Patrick Shannon; Diane Myles-Reid; Susan Blaser; Tim V Mieghem; Halenur Yavuz-Kienle; Heyko Skladny; Kristen Miller; Miereia D T Riera; Silvia A Martínez; Eduardo F Tizzano; Lucie Dupuis; Dimitri James Stavropoulos; Vanda McNiven; Roberto Mendoza-Londono; Alison M Elliott; Robert S Phillips; Gavin Chapman; Sally L Dunwoodie
Journal:  Hum Mutat       Date:  2021-05-16       Impact factor: 4.700

Review 6.  Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Authors:  Kelly R Jacobs; Gloria Castellano-Gonzalez; Gilles J Guillemin; David B Lovejoy
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 7.  Pyridoxal 5'-Phosphate-Dependent Enzymes at the Crossroads of Host-Microbe Tryptophan Metabolism.

Authors:  Barbara Cellini; Teresa Zelante; Mirco Dindo; Marina M Bellet; Giorgia Renga; Luigina Romani; Claudio Costantini
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 8.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

9.  Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies.

Authors:  Guang Yang; T Matt Holl; Yang Liu; Yi Li; Xiaozhi Lu; Nathan I Nicely; Thomas B Kepler; S Munir Alam; Hua-Xin Liao; Derek W Cain; Leonard Spicer; John L VandeBerg; Barton F Haynes; Garnett Kelsoe
Journal:  J Exp Med       Date:  2013-01-28       Impact factor: 14.307

10.  Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells.

Authors:  Lei Yu; Shao Thing Teoh; Elliot Ensink; Martin P Ogrodzinski; Che Yang; Ana I Vazquez; Sophia Y Lunt
Journal:  Cancer Metab       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.